Go to the list of all blogs
Allana's Avatar
published in Blogs
Sep 03, 2026
Cognex (CGNX) Shares Retreat -16% After Record Q2 Results

Cognex (CGNX) Shares Retreat -16% After Record Q2 Results

Key Takeaways

  • Cognex shares declined roughly 16% over the past 30 days, falling from a closing price near $71.52 to about $59.94.
  • The pullback followed a strong run-up into second-quarter 2026 earnings and largely reflects post-earnings profit-taking after record results.
  • Second-quarter 2026 revenue rose 17% year over year to a record $291.3 million, and adjusted EPS of $0.45 beat consensus, though revenue came in slightly below estimates.
  • Management raised full-year 2026 guidance and highlighted AI-enabled machine vision and data center supply-chain momentum.
  • An elevated valuation, a softer automotive and European backdrop, and expected memory-price margin pressure contributed to the decline.

Cognex Corporation’s Business and Competitive Position

Cognex Corporation is a global leader in machine vision and industrial barcode reading. Headquartered in Natick, Massachusetts, the company designs vision systems, vision sensors, and software—including its In-Sight product family, DataMan barcode readers, and the OneVision platform—that help manufacturers automate inspection, measurement, identification, and quality control across factory floors and logistics networks.

Cognex serves a diversified set of end markets, including logistics, packaging, consumer electronics, automotive, and semiconductor, and is increasingly targeting the data center supply chain. Its competitive strengths include a leading position in AI-enabled vision technology, a broad installed base, a land-and-expand customer strategy, and a strong balance sheet with roughly $755 million in cash and investments and no debt as of early July 2026. Investors follow the stock closely because CGNX is viewed as a benchmark for industrial automation spending and AI adoption in manufacturing. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

CGNX Stock Price Performance Over the Past 30 Days and Quarter

Over the last 30 days, CGNX fell approximately 16%, moving from a closing price of about $71.52 on August 4 to roughly $59.94 in early September. The stock briefly traded near the $72 level in early August before giving back those gains.

Over the trailing quarter, the decline has been more modest, with the shares down roughly 9% from early-June levels near $66. The quarterly trend has been volatile rather than linear: the stock twice approached the $72 area—once in late June and again in early August—before each rally faded. The net result is a stock that remains well below its recent highs despite solid underlying fundamentals.

What Shaped the Recent 30-Day Move in CGNX

The 30-day move was shaped primarily by the reaction to Cognex's second-quarter 2026 earnings, reported after the close on August 5. Shares had climbed into the report near their 52-week high, which made the stock vulnerable to a "sell-the-news" response even after a strong quarter.

Cognex delivered record quarterly revenue of $291.3 million, up 17% year over year, and adjusted diluted EPS of $0.45, an 80% increase that beat the consensus estimate of $0.42. Adjusted EBITDA margin expanded 1,150 basis points to 32.2%, marking an eighth consecutive quarter of margin expansion. However, revenue came in slightly below consensus, and management flagged a softer automotive market, a 15% year-over-year decline in European revenue, and roughly 75 basis points of gross-margin pressure expected in the third quarter from rising memory prices.

Valuation also played a role. With shares trading at a forward price-to-earnings multiple near 48 and well above 80 times trailing earnings before the pullback, investors had priced in substantial growth, leaving limited room for error. The combination of a minor revenue miss, margin headwinds, and profit-taking after a strong run drove the subsequent decline. One thing that stands out is how quickly sentiment shifted once those details emerged.

Quarterly Fundamentals and Strategic Momentum

The broader quarterly story is one of strengthening fundamentals meeting a demanding valuation. Earlier in the period, first-quarter 2026 results showed revenue growth of 24% year over year and adjusted EBITDA margin of 26.9%, reinforcing a multi-quarter recovery narrative. The second-quarter report extended that trend with record revenue, significant operating leverage, and raised full-year guidance for revenue of $1.13 billion to $1.15 billion.

Strategic initiatives also supported the narrative. Cognex announced the general availability of its OneVision AI platform, expanded into the data center supply chain—an area management said is growing more than 30% year over year—and added roughly 4,500 new customers year to date. An improving industrial cycle, with the U.S. Purchasing Managers Index in expansion territory for seven consecutive months, provided additional support. Yet even as fundamentals improved, the stock's advance into early August proved difficult to sustain, and the shares retreated as the enthusiasm ran ahead of near-term results. I’m watching this closely as the data center opportunity continues to develop.

Key Factors to Monitor for CGNX Going Forward

Several factors are likely to shape Cognex's trajectory in the months ahead. The company's third-quarter earnings, expected in late October, will test whether the demand environment and margin expansion remain intact. Management guided third-quarter revenue of $300 million to $320 million and adjusted EPS of $0.50 to $0.54.

Investors will also be watching the data center supply-chain opportunity, which remains a low-single-digit share of revenue but is growing quickly, along with continued momentum in logistics, packaging, electronics, and semiconductor end markets. On the risk side, memory-price increases, automotive and European softness, macroeconomic uncertainty, and potential tariff impacts could pressure margins and demand. Analyst sentiment has remained broadly positive, with a buy consensus and a mean price target near $77 reported around the second-quarter print. As always, individual results will depend on execution, demand trends, and broader market conditions. From what I see, the upcoming print will be telling.

Using Tickeron’s AI Tools in My Research

When evaluating names like CGNX, I find it helpful to review automated strategies through Tickeron’s Trending AI Robots. The page highlights top-performing bots across different timeframes and approaches, letting me compare signals without depending on a single method. Historical performance data is readily available, which adds useful context when assessing momentum in industrial automation stocks.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CGNX

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


CGNX in downward trend: 10-day moving average broke below 50-day moving average on August 19, 2026

The 10-day moving average for CGNX crossed bearishly below the 50-day moving average on August 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

CGNX moved below its 50-day moving average on August 18, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CGNX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CGNX entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 03, 2026. You may want to consider a long position or call options on CGNX as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CGNX just turned positive on September 04, 2026. Looking at past instances where CGNX's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CGNX advanced for three days, in of 283 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CGNX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.369) is normal, around the industry mean (4.207). P/E Ratio (59.317) is within average values for comparable stocks, (83.145). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.176). Dividend Yield (0.005) settles around the average of (0.012) among similar stocks. P/S Ratio (9.588) is also within normal values, averaging (33.028).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CGNX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.

Industry description

This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.

Market Cap

The average market capitalization across the Electronic Equipment/Instruments Industry is 8.76B. The market cap for tickers in the group ranges from 27.54K to 122.53B. KYCCF holds the highest valuation in this group at 122.53B. The lowest valued company is CSEC at 27.54K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Equipment/Instruments Industry was -4%. For the same Industry, the average monthly price growth was -10%, and the average quarterly price growth was 4%. ARBE experienced the highest price growth at 26%, while FCUV experienced the biggest fall at -64%.

Volume

The average weekly volume growth across all stocks in the Electronic Equipment/Instruments Industry was 52%. For the same stocks of the Industry, the average monthly volume growth was 13% and the average quarterly volume growth was 23%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 59
Price Growth Rating: 58
SMR Rating: 78
Profit Risk Rating: 81
Seasonality Score: -20 (-100 ... +100)
View a ticker or compare two or three
CGNX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of machine vision computer systems

Industry ElectronicEquipmentInstruments

Profile
Details
Industry
Electronic Production Equipment
Address
One Vision Drive
Phone
+1 508 650-3000
Employees
2745
Web
https://www.cognex.com
Interact to see
Advertisement
HIMS shares surged approximately +43.85% in premarket trading on Monday, March 9, 2026, rising from a prior close of $15.74 to around $22.80. Primary catalyst: Novo Nordisk officially ended its patent infringement lawsuit against Hims & Hers and announced a landmark partnership to distribute branded Wegovy through the Hims platform at $599/month.
XENE shares surged approximately +45.93% in premarket trading on March 9, 2026, one of the largest single-session moves in the company's history. The primary catalyst: Xenon announced positive topline Phase 3 X-TOLE2 results for its lead drug candidate azetukalner in focal onset seizures (FOS), meeting the primary endpoint with overwhelming statistical significance.
Shares of OLMA dropped approximately 41% in Monday's session, one of the steepest single-day declines in the company's history. The primary catalyst was Roche's Phase 3 persevERA trial failure — a late-stage study of giredestrant, a closely competing selective estrogen receptor degrader (SERD), which missed its primary endpoint of statistically significant improvement in progression-free survival.
RLMD shares surged approximately +40% at the open on March 9, 2026, rising from a prior close of $4.45 to approximately $6.23, driven by a major clinical trial readout. The primary catalyst was the announcement of 12-month interim data from the Phase 2 trial of NDV-01, Relmada's lead oncology candidate, in patients with high-risk non-muscle invasive bladder cancer (NMIBC) — results that significantly exceeded historical benchmarks.
CRCL surged +8.66% on Monday, March 9, 2026, rising from a prior close of $101.94 to trade at $110.77 intraday. The primary catalyst is a landmark stablecoin milestone: Circle's USDC overtook Tether as the dominant stablecoin by transfer volume, accounting for approximately 70% of all stablecoin transfer activity as total stablecoin transfers hit $1.8 trillion in February.
Carnival Corporation (CCL) shares fell approximately -7.60% in Monday's session, dropping from a Friday close of $25.79 to around $23.83. The primary catalyst is a broad market sell-off driven by intensifying recession fears, with the S&P 500 and consumer discretionary names bearing the brunt of the pressure.
Shares of Bloom Energy (BE) are surging approximately +10.30% in Monday's session, rebounding sharply from a steep -15.50% selloff on Friday, March 6, 2026. Friday's decline was triggered by an Oracle-OpenAI data center project update that spooked energy infrastructure investors; Monday's move reflects aggressive dip-buying and a sentiment reset.
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.
Shares of ARQ plunged approximately 27.50% in premarket trading on March 10, 2026, from a prior close of $3.20 to roughly $2.32. The primary catalyst was a deeply disappointing Q4 2025 earnings report, which revealed a net loss of $50.0 million for the quarter versus a net loss of $1.3 million in Q4 2024.
RAIL shares fell approximately 15% in premarket trading on March 10, 2026, following a steep after-hours reaction to disappointing Q4 2025 earnings results released after the close on March 9. The primary catalyst was a significant revenue miss: Q4 revenue came in at $125.6 million, well below consensus estimates near $144–$160 million, representing an 8.8% year-over-year decline.
ZVRA shares surged approximately +17.86% on March 10, 2026, driven by a blockbuster Q4 and full-year 2025 earnings report released before the market open. Primary catalyst: Q4 2025 EPS of $0.19 crushed the consensus estimate of $0.05 — a 280% beat — while revenue of $34.1 million exceeded forecasts by 21.57%.
LITE surged +14.73% on Monday, March 9, 2026, closing at $640.69 versus a prior close of $558.44 on March 6. The primary catalyst was the landmark $2 billion strategic investment by NVIDIA announced March 2, with the market continuing to price in its full implications following a brief post-announcement pullback.
Shares of BNTX fell approximately 22% on Tuesday, March 10, 2026, following a dual shock of disappointing full-year guidance and a surprise leadership upheaval. The primary catalyst was BioNTech's Q4 2025 earnings report, which included a 2026 revenue outlook of €2.0–€2.3 billion — well below analyst consensus and signaling continued pressure from declining COVID-19 vaccine demand.
CNC shares fell approximately 10% during Tuesday's session, extending a prolonged selloff in the managed care sector. The primary catalyst is intensifying investor concern over federal Medicaid and ACA funding cuts tied to the "One Big Beautiful Bill Act" (OBBBA), which threatens to shrink the government-sponsored insurance pools that Centene depends on for the majority of its revenue.
Technology recently peaked near 35% of the S&P 500 and has slipped over the last year, while Energy plus Materials remain near historically low combined weight at roughly 6%, which suggests the gap is still unusually wide.
Average daily equity purchases by retail investors on S&P 500 down days in 2026 are at the highest level on record, running about 100% above the peak intensity seen during the 2021 meme‑stock boom.
Over the past two weeks, PLTR has climbed from roughly the high‑130s to the mid‑150s, a gain of about 12–14%, with a series of strong up days between March 2 and March 6.
AVAV shares dropped approximately 10% in premarket trading on March 11, 2026, following a disappointing Q3 fiscal 2026 earnings report released after the prior session's close. Q3 revenue of $408.0 million came in far below analyst consensus of approximately $475–$488 million, representing a massive top-line miss.
KOS shares are down approximately 20% in premarket trading on March 11, 2026, having shed roughly 20.31% across the last two sessions (Tuesday close and premarket Wednesday). The primary catalyst is Kosmos Energy's announcement of a massive $185.25 million public equity offering priced at $1.90 per share — a steep discount to recent trading levels.
Cognex (CGNX) Shares Retreat -16% After Record Q2 Results